21
Oral Aripiprazole Open-Label Rollover Study
Condition(s):SchizophreniaLast Updated:September 27, 2013Completed
Aripiprazole: 434 Clinical Trials, Page 3 of 44
Hide Studies Not Open or Pending
22
Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World Study
Condition(s):Acute Schizophrenia EpisodeLast Updated:February 5, 2021Completed
23
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
Condition(s):SchizophreniaLast Updated:March 4, 2015Terminated
24
A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia
Condition(s):SchizophreniaLast Updated:September 21, 2015Terminated
25
Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
Condition(s):Bipolar Disorder; Alcoholism; Alcohol AbuseLast Updated:February 1, 2022Recruiting
26
A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot
Condition(s):SchizophreniaLast Updated:January 22, 2014Completed
27
Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy
Condition(s):Anesthesia; Analgesia; HysterotomyLast Updated:December 21, 2022Completed
28
Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette’s Disorder
Condition(s):Tourette’s DisorderLast Updated:October 7, 2021Completed
29
A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Condition(s):Schizophrenia; Bipolar 1 Disorder; Major Depressive DisorderLast Updated:November 8, 2019Terminated
30
Aripiprazole and Prolactin Study
Condition(s):HyperprolactinemiaLast Updated:May 28, 2015Completed